Exact Mass: 431.1821
Exact Mass Matches: 431.1821
Found 135 metabolites which its exact mass value is equals to given mass value 431.1821
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Glenvastatin
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites
Lafutidine
Lafutidine is a histamine H2-receptor antagonist that inhibits histamine-stimulated gastric acid secretion. Due to the resulting reduction in gastric volume and acidity, lafutidine can be used to treat ulcers and reflux. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
Lafutidine
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
Ala Met Asn Pro
Ala Met Pro Asn
Ala Asn Met Pro
Ala Asn Asn Asn
Ala Asn Pro Met
Ala Pro Met Asn
Ala Pro Asn Met
Cys Asn Pro Val
Cys Asn Val Pro
Cys Pro Asn Val
Cys Pro Val Asn
Cys Val Asn Pro
Cys Val Pro Asn
Gly Met Pro Gln
Gly Met Gln Pro
Gly Asn Asn Gln
Gly Asn Gln Asn
Gly Pro Met Gln
Gly Pro Gln Met
Gly Gln Met Pro
Gly Gln Asn Asn
Gly Gln Pro Met
Met Ala Asn Pro
Met Ala Pro Asn
Met Gly Pro Gln
Met Gly Gln Pro
Met Asn Ala Pro
Met Asn Pro Ala
Met Pro Ala Asn
Met Pro Gly Gln
Met Pro Asn Ala
Met Pro Gln Gly
Met Gln Gly Pro
Met Gln Pro Gly
Asn Ala Met Pro
Asn Ala Asn Asn
Asn Ala Pro Met
Asn Cys Pro Val
Asn Cys Val Pro
Asn Gly Asn Gln
Asn Gly Gln Asn
Asn Met Ala Pro
Asn Met Pro Ala
Asn Asn Ala Asn
Asn Asn Gly Gln
Asn Asn Asn Ala
Asn Asn Gln Gly
Asn Pro Ala Met
Asn Pro Cys Val
Asn Pro Met Ala
Asn Pro Val Cys
Asn Gln Gly Asn
Asn Gln Asn Gly
Asn Val Cys Pro
Asn Val Pro Cys
Pro Ala Met Asn
Pro Ala Asn Met
Pro Cys Asn Val
Pro Cys Val Asn
Pro Gly Met Gln
Pro Gly Gln Met
Pro Met Ala Asn
Pro Met Gly Gln
Pro Met Asn Ala
Pro Met Gln Gly
Pro Asn Ala Met
Pro Asn Cys Val
Pro Asn Met Ala
Pro Asn Val Cys
Pro Gln Gly Met
Pro Gln Met Gly
Pro Val Cys Asn
Pro Val Asn Cys
Gln Gly Met Pro
Gln Gly Asn Asn
Gln Gly Pro Met
Gln Met Gly Pro
Gln Met Pro Gly
Gln Asn Gly Asn
Gln Asn Asn Gly
Gln Pro Gly Met
Gln Pro Met Gly
Val Cys Asn Pro
Val Cys Pro Asn
Val Asn Cys Pro
Val Asn Pro Cys
Val Pro Cys Asn
Val Pro Asn Cys
L-Octahydroindole-2-carboxylic acid benzyl ester 4-methylbenzenesulfonate
Ethaverine hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor C93038 - Cation Channel Blocker
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-threonine phenylmethyl ester
2-Methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one
Xanomeline tartrate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs Xanomeline (LY 246708) is the potent agonist of muscarinic M1/M4 receptor with antipsychotic-like activity. Xanomeline (LY 246708) increases neuronal excitability. Xanomeline (LY 246708) can be used for the research of schizophrenia[1][2][3].